Lisa Liang
Overview
Explore the profile of Lisa Liang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
237
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Saulnier O, Zagozewski J, Liang L, Hendrikse L, Layug P, Gordon V, et al.
Nat Cell Biol
. 2024 Jul;
26(8):1233-1246.
PMID: 39025928
OTX2 is a transcription factor and known driver in medulloblastoma (MB), where it is amplified in a subset of tumours and overexpressed in most cases of group 3 and group...
2.
Borlase S, DeCarlo A, Coudiere-Morrison L, Liang L, Porter C, Ramaswamy V, et al.
Cell Death Discov
. 2023 Sep;
9(1):347.
PMID: 37726268
Sonic Hedgehog (SHH) medulloblastomas (MBs) exhibit an intermediate prognosis and extensive intertumoral heterogeneity. While SHH pathway antagonists are effective in post-pubertal patients, younger patients exhibit significant side effects, and tumors...
3.
Zagozewski J, Borlase S, Guppy B, Coudiere-Morrison L, Shahriary G, Gordon V, et al.
Commun Biol
. 2022 Jul;
5(1):697.
PMID: 35835937
Medulloblastoma (MB) is the most common primary malignant pediatric brain cancer. We recently identified novel roles for the MEK/MAPK pathway in regulating human Sonic Hedgehog (SHH) MB tumorigenesis. The MEK...
4.
Parker J, Fung E, Trejo-Martin A, Liang L, Gibbs K, Bandara S, et al.
Regul Toxicol Pharmacol
. 2022 Jul;
134:105224.
PMID: 35817210
Inhibition of the human ether-à-go-go (hERG) channel may lead to QT prolongation and fatal arrhythmia. While pharmaceutical drug candidates that exhibit potent hERG channel inhibition often fail early in development,...
5.
Liang L, Coudiere-Morrison L, Tatari N, Stromecki M, Fresnoza A, Porter C, et al.
Cancer Res
. 2018 Jun;
78(16):4745-4759.
PMID: 29930101
The extensive heterogeneity both between and within the medulloblastoma subgroups underscores a critical need for variant-specific biomarkers and therapeutic strategies. We previously identified a role for the CD271/p75 neurotrophin receptor...
6.
Moraya A, Ali J, Samadder P, Liang L, Morrison L, Werbowetski-Ogilvie T, et al.
J Exp Clin Cancer Res
. 2017 May;
36(1):67.
PMID: 28499442
Background: Chemotherapy resistance is one of the major factors contributing to mortality from human epithelial ovarian cancer (EOC). Identifying drugs that can effectively kill chemotherapy-resistant EOC cells would be a...
7.
Liang L, Aiken C, McClelland R, Morrison L, Tatari N, Remke M, et al.
Oncotarget
. 2015 Oct;
6(36):38881-900.
PMID: 26497209
Major research efforts have focused on defining cell surface marker profiles for characterization and selection of brain tumor stem/progenitor cells. Medulloblastoma is the most common primary malignant pediatric brain cancer...
8.
Morrison L, McClelland R, Aiken C, Bridges M, Liang L, Wang X, et al.
Neoplasia
. 2013 Apr;
15(4):384-98.
PMID: 23555184
Medulloblastoma (MB) is the most common malignant primary pediatric brain tumor. Major research efforts have focused on characterizing and targeting putative brain tumor stem or propagating cell populations from the...
9.
Liang L, Chantry C, Styne D, Stephensen C
Eur J Pediatr
. 2010 Jun;
169(11):1337-44.
PMID: 20532799
This cross-sectional study assessed vitamin D status of healthy infants and young children undergoing routine care in a medical center pediatric clinic in Sacramento, CA, and evaluated associations of status...
10.
Tse W, Frisina P, Halbig T, Gracies J, Liang L, Tarshish C, et al.
J Am Med Dir Assoc
. 2008 Nov;
9(9):670-5.
PMID: 18992700
Objective: To determine the effects of dopaminergic medication withdrawal in an elderly, demented and minimally ambulatory nursing home population with parkinsonism in New York City. Methods: In our double-blind, randomized...